Literature DB >> 11677599

Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria.

F Schlünzen1, R Zarivach, J Harms, A Bashan, A Tocilj, R Albrecht, A Yonath, F Franceschi.   

Abstract

Ribosomes, the site of protein synthesis, are a major target for natural and synthetic antibiotics. Detailed knowledge of antibiotic binding sites is central to understanding the mechanisms of drug action. Conversely, drugs are excellent tools for studying the ribosome function. To elucidate the structural basis of ribosome-antibiotic interactions, we determined the high-resolution X-ray structures of the 50S ribosomal subunit of the eubacterium Deinococcus radiodurans, complexed with the clinically relevant antibiotics chloramphenicol, clindamycin and the three macrolides erythromycin, clarithromycin and roxithromycin. We found that antibiotic binding sites are composed exclusively of segments of 23S ribosomal RNA at the peptidyl transferase cavity and do not involve any interaction of the drugs with ribosomal proteins. Here we report the details of antibiotic interactions with the components of their binding sites. Our results also show the importance of putative Mg+2 ions for the binding of some drugs. This structural analysis should facilitate rational drug design.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677599     DOI: 10.1038/35101544

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  300 in total

1.  Inhibition of protein synthesis by aminoglycoside-arginine conjugates.

Authors:  Marjolaine Carriere; Veerappan Vijayabaskar; Drew Applefield; Isabelle Harvey; Philippe Garneau; Jon Lorsch; Aviva Lapidot; Jerry Pelletier
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

2.  Resistance to macrolides and related antibiotics in Streptococcus pneumoniae.

Authors:  Roland Leclercq; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 3.  5 S rRNA: structure and interactions.

Authors:  Maciej Szymański; Mirosława Z Barciszewska; Volker A Erdmann; Jan Barciszewski
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

Review 4.  After the ribosome structure: how does translocation work?

Authors:  Simpson Joseph
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

5.  RNA structure comparison, motif search and discovery using a reduced representation of RNA conformational space.

Authors:  Carlos M Duarte; Leven M Wadley; Anna Marie Pyle
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

6.  The non-Watson-Crick base pairs and their associated isostericity matrices.

Authors:  Neocles B Leontis; Jesse Stombaugh; Eric Westhof
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

7.  Three-dimensional motifs from the SCOR, structural classification of RNA database: extruded strands, base triples, tetraloops and U-turns.

Authors:  Peter S Klosterman; Donna K Hendrix; Makio Tamura; Stephen R Holbrook; Steven E Brenner
Journal:  Nucleic Acids Res       Date:  2004-04-30       Impact factor: 16.971

8.  Mutational analysis of basic residues in the N-terminus of the rRNA:m6A methyltransferase ErmC'.

Authors:  G Maravić; J M Bujnicki; M Flögel
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

9.  Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.

Authors:  S Pereyre; P Gonzalez; B De Barbeyrac; A Darnige; H Renaudin; A Charron; S Raherison; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  Structural analysis of QdtB, an aminotransferase required for the biosynthesis of dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose.

Authors:  James B Thoden; Christina Schäffer; Paul Messner; Hazel M Holden
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.